Helper B Cells Promote Cytotoxic T Cell Survival and Proliferation Independently of Antigen Presentation through CD27/CD70 Interactions1

CD8-expressing cytotoxic T cell (CTL) interactions with APCs and helper T cells determine their function and ability to survive. In this study, we describe a novel interaction independent of Ag presentation between activated CTLs and bystander CD19-expressing B lymphocytes. Ag-stimulated CTLs serially engage autologous B lymphocytes through CD27/CD70 contact that promotes their survival and proliferation. Moreover, these interactions induce the release of proinflammatory cytokines that follows two general patterns: 1) an epitope-dependent enhancement of cytokine release, and 2) a previously undiscovered coordinate release of cytokines independent of epitope exposure. The latter includes chemoattractants targeting activated T cells. As a result, activated T cells are attracted to B cells, which exert a “helper” role in lymphatic organs or in areas of inflammation. This observation provides a mechanistic explanation to previously reported experimental observations suggesting that B cells are required for T cell priming in vivo.

[1]  Michael J. Ramsbottom,et al.  Rituximab reduces B cells and T cells in cerebrospinal fluid of multiple sclerosis patients , 2006, Journal of Neuroimmunology.

[2]  M. Takiguchi,et al.  Functional and phenotypic analysis of human memory CD8+ T cells expressing CXCR3 , 2006, Journal of leukocyte biology.

[3]  S. Iida,et al.  Specific recruitment of CC chemokine receptor 4-positive regulatory T cells in Hodgkin lymphoma fosters immune privilege. , 2006, Cancer research.

[4]  K. Moore,et al.  Chemokine CXCL10 Promotes Atherogenesis by Modulating the Local Balance of Effector and Regulatory T Cells , 2006, Circulation.

[5]  S. Liao,et al.  Lymphoid organ development: from ontogeny to neogenesis , 2006, Nature Immunology.

[6]  E. Wang.  RNA amplification for successful gene profiling analysis , 2005, Journal of Translational Medicine.

[7]  P. Kourilsky,et al.  Lineage relationships, homeostasis, and recall capacities of central– and effector–memory CD8 T cells in vivo , 2005, The Journal of experimental medicine.

[8]  T. Waldmann,et al.  IL-15/IL-15Rα-mediated avidity maturation of memory CD8 + T cells , 2004 .

[9]  Mark Connors,et al.  Quiescent phenotype of tumor-specific CD8+ T cells following immunization. , 2004, Blood.

[10]  Antonio Lanzavecchia,et al.  Chemokine Receptor Expression Identifies Pre–T Helper (Th)1, Pre–Th2, and Nonpolarized Cells among Human CD4+ Central Memory T Cells , 2004, The Journal of experimental medicine.

[11]  S. Adams,et al.  Ambiguous allele combinations in HLA Class I and Class II sequence-based typing: when precise nucleotide sequencing leads to imprecise allele identification , 2004, Journal of Translational Medicine.

[12]  J. Borst,et al.  CD27 Is Acquired by Primed B Cells at the Centroblast Stage and Promotes Germinal Center Formation1 , 2004, The Journal of Immunology.

[13]  A. Oxenius,et al.  Immediate Cytotoxicity But Not Degranulation Distinguishes Effector and Memory Subsets of CD8+ T Cells , 2004, The Journal of experimental medicine.

[14]  T. Sørensen.  Targeting the chemokine receptor CXCR3 and its ligand CXCL10 in the central nervous system: potential therapy for inflammatory demyelinating disease? , 2004, Current neurovascular research.

[15]  A. Luster,et al.  IP-10-induced recruitment of CXCR3 host T cells is required for small bowel allograft rejection. , 2004, Gastroenterology.

[16]  J. Borst,et al.  CD27 Promotes Survival of Activated T Cells and Complements CD28 in Generation and Establishment of the Effector T Cell Pool , 2003, The Journal of experimental medicine.

[17]  E. Butcher,et al.  Chemokines in the systemic organization of immunity , 2003, Immunological reviews.

[18]  M. Sarwal,et al.  Molecular heterogeneity in acute renal allograft rejection identified by DNA microarray profiling. , 2003, The New England journal of medicine.

[19]  F. Sallusto,et al.  Proliferation and differentiation potential of human CD8+ memory T-cell subsets in response to antigen or homeostatic cytokines. , 2003, Blood.

[20]  Rustom Antia,et al.  Lineage relationship and protective immunity of memory CD8 T cell subsets , 2003, Nature Immunology.

[21]  A. Cumano,et al.  The repertoires of circulating human CD8(+) central and effector memory T cell subsets are largely distinct. , 2003, Immunity.

[22]  Susan M. Kaech,et al.  Molecular and Functional Profiling of Memory CD8 T Cell Differentiation , 2002, Cell.

[23]  B. Rocha,et al.  A Role for CD40 Expression on CD8+ T Cells in the Generation of CD8+ T Cell Memory , 2002, Science.

[24]  F. Sallusto,et al.  T cell priming by dendritic cells: thresholds for proliferation, differentiation and death and intraclonal functional diversification , 2002, European journal of immunology.

[25]  A. Luster,et al.  Donor-Derived Ip-10 Initiates Development of Acute Allograft Rejection , 2001, The Journal of experimental medicine.

[26]  S. Swain,et al.  Reciprocal regulation of polarized cytokine production by effector B and T cells , 2000, Nature Immunology.

[27]  T. Schumacher,et al.  CD27 is required for generation and long-term maintenance of T cell immunity , 2000, Nature Immunology.

[28]  L. Trentin,et al.  CXC chemokines IP-10 and mig expression and direct migration of pulmonary CD8+/CXCR3+ T cells in the lungs of patients with HIV infection and T-cell alveolitis. , 2000, American journal of respiratory and critical care medicine.

[29]  F. Marincola,et al.  High-fidelity mRNA amplification for gene profiling , 2000, Nature Biotechnology.

[30]  V. Engelhard,et al.  Terminal modifications inhibit proteolytic degradation of an immunogenic mart‐127–35 peptide: Implications for peptide vaccines , 1999, International journal of cancer.

[31]  F. Sallusto,et al.  Three chemokines with potential functions in T lymphocyte‐independent and ‐dependent B lymphocyte stimulation , 1999, European journal of immunology.

[32]  F. Marincola,et al.  Functional dissociation between local and systemic immune response during anti-melanoma peptide vaccination. , 1998, Journal of immunology.

[33]  Christoph Schaniel,et al.  Activated Murine B Lymphocytes and Dendritic Cells Produce a Novel CC Chemokine which Acts Selectively on Activated T Cells , 1998, The Journal of experimental medicine.

[34]  R. Brunham,et al.  Gene knockout B cell-deficient mice demonstrate that B cells play an important role in the initiation of T cell responses to Chlamydia trachomatis (mouse pneumonitis) lung infection. , 1998, Journal of immunology.

[35]  A. Lanzavecchia.  Understanding the Mechanisms of Sustained Signaling and T Cell Activation , 1997, The Journal of experimental medicine.

[36]  J. Thompson,et al.  Isolation of tyrosinase-specific CD8+ and CD4+ T cell clones from the peripheral blood of melanoma patients following in vitro stimulation with recombinant vaccinia virus. , 1996, Journal of immunology.

[37]  P. Greenberg,et al.  The role of B cells for in vivo T cell responses to a Friend virus-induced leukemia. , 1990, Science.

[38]  P. Cresswell,et al.  Presentation of viral antigen controlled by a gene in the major histocompatibility complex , 1990, Nature.

[39]  J. Bonner,et al.  Differentiation , 1968, Nature.

[40]  R. Ransohoff,et al.  Chemokine receptor CXCR3: an unexpected enigma. , 2005, Current topics in developmental biology.